IP Library › Granted Patent US 12,130,283
Granted Patent B2
US 12,130,283 · App. 16/985,744 · Granted Oct 29, 2024

Methods, systems and compositions for functional in vitro cellular models of mammalian systems

Inventor: James J. Hickman (Orlando, FL)
Assignee: University of Central Florida Research Foundation, Inc.
G01N33/502B01L3/502761C12M21/08C12M35/02C12M41/48G01N33/4836G01N33/5088B01L2200/0684B01L2200/0689B01L2300/0636B01L2300/0645B01L2300/0663B01L2300/0816
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,130,283
App. No.
16/985,744
Granted
Oct 29, 2024
Kind
B2
Abstract

The present invention comprises methods, systems and compositions comprising cell culture analog systems, comprising components which optionally comprise biologically functional cells, and the components and systems function similarly to in vivo conditions.

Claims (31)

1. A method of assessing one or more effects of varying an input variable or a cell culture characteristic on a microfluidic cell culture analog system, the method comprising:

varying an input variable or a cell culture characteristic to which a microfluidic cell culture analog system is exposed, the microfluidic cell culture analog system comprising one or more organ components, each organ component configured to simulate an organ and comprising (i) one or more chambers, (ii) cell cultured on a surface, and (iii) if the microfluidic cell culture analog system comprises more than one organ component, microfluidic couplings between organ components;

recording, over a duration of time, changes in measured electrophysiological properties, changes in measured contractile properties, or both in response to the varying input variable or cell culture characteristic;

in which the electrophysiological properties, if recorded, are measured from a first population of cells cultured on a surface comprising a microelectrode array housed in a first chamber; and

in which the contractile properties, if recorded, are measured from a second population of cells cultured on a surface comprising a cantilever array housed in a second chamber;

the recorded changes providing an assessment of the one or more effects of varying an input variable or a cell culture characteristic; and

mechanically actuating the second population of cells using the cantilever array.

2. The method of claim 1 , wherein the duration of time is a time period of days.

3. The method of claim 1 , further comprising multiple microfluidically coupled organ components, wherein the multiple microfluidically coupled organ components include a cardiac component, and the method further comprises measuring at least one electrophysiological property from cardiomyocyte cells cultured on a microelectrode array of the cardiac component and simultaneously measuring at least one contractile property from cardiomyocyte cells cultures on a cantilever array of the cardiac component.

4. The method of claim 3 , wherein the multiple microfluidically coupled organ components further include a hepatic component.

5. The method of claim 1 , further comprising multiple microfluidically coupled organ components, wherein the multiple microfluidically coupled organ components include a neural component and a skeletal muscle component, and the method further comprises measuring at least one electrophysiological property from neurons cultured on a microelectrode array of the neural component and simultaneously measuring at least one contractile property from skeletal muscles cultured on a cantilever array of the skeletal muscle component.

6. The method of claim 5 , wherein the multiple microfluidically coupled organ components further include a hepatic component.

7. The method of claim 1 , further comprising measuring changes in the input variable or the cell culture characteristic over the duration of time.

8. The method of claim 1 , wherein changes in electrophysiological and contractile properties in response to the varying input variable or cell culture characteristic are measured simultaneously.

9. A method of assessing one or more effects of a metabolism of an input variable using a microfluidic cell culture analog system, the method comprising:

providing the microfluidic cell culture analog system, wherein the microfluidic cell culture analog system comprises a hepatic organ component and at least a first and second other organ component, each organ component configured to simulate an organ and comprising (i) one or more chambers, (ii) cell cultured on a surface, and (iii) microfluidic couplings between organ components;

contacting liver cells of the hepatic organ component with an input variable under conditions in which the liver cells at least partially metabolize the input variable into one or more hepatic metabolites;

allowing the input variable and the one or more hepatic metabolites to flow through the microfluidic cell culture analog system;

recording, over a duration of time, changes in simultaneously measured electrophysiological and contractile properties in response to the input variable and the one or more hepatic metabolites;

in which the electrophysiological properties are measured from a first population of cells cultured on a microelectrode array of the first organ component and the contractile properties are measured from a second population of cells cultured on a cantilever array of the second organ component;

the recorded changes providing an assessment of the one or more effects of the metabolism of the input variable.

10. The method of claim 9 , further comprising comparing the changes in the simultaneously measured electrophysiological and contractile properties to information about the behavior of cells that have not been exposed to the one or more hepatic metabolites.

11. The method of claim 10 , further comprising gathering information about behavior of cells that have not been exposed to the one or more hepatic metabolites using a microfluidic cell culture analog system without liver cells.

12. The method of claim 9 , wherein the duration of time is a time period of days.

13. The method of claim 9 , wherein the at least a first and second other organ components include a cardiac component, and the method further comprises measuring at least one electrophysiological property from cardiomyocyte cells cultured on a microelectrode array of the cardiac component and simultaneously measuring at least one contractile property from cardiomyocyte cells cultured on a cantilever array of the cardiac component.

14. The method of claim 9 , wherein the at least a first and second other organ components include a neural component and a skeletal muscle component, and the method further comprises measuring at least one electrophysiological property from neurons cultured on a microelectrode array of the neural component and simultaneously measuring at least one contractile property from skeletal muscles cultured on a cantilever array of the skeletal muscle component.

15. The method of claim 9 , further comprising mechanically stimulating the second population of cells using the cantilever array.

16. The method of claim 1 , wherein the cantilever array comprises piezoresistive materials.

17. The method of claim 9 , wherein the cantilever array comprises piezoresistive materials.

18. The method of claim 1 , wherein the cantilever array is formed of silicon.

19. The method of claim 9 , wherein the cantilever array is formed of silicon.

Assignments (2)
CONFIRMATORY LICENSE Recorded May 12, 2026
From: UNIVERSITY OF CENTRAL FLORIDA
To: THE GOVERNMENT OF THE UNITED STATES, AS REPRESENTED BY THE DIRECTOR OF THE DEFENSE HEALTH AGENCY
Reel/Frame 074627/0770 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 7, 2020
From: HICKMAN, JAMES J.
To: UNIVERSITY OF CENTRAL FLORIDA RESEARCH FOUNDATION, INC.
Reel/Frame 053428/0744 →
Continuity (4)
Continuation 14422082
Provisional Application 61789184 · Mar 15, 2013
Provisional Application 61684168 · Aug 17, 2012
Related Publication 20210003554A1 · Jan 7, 2021